期刊文献+

脂质纳米粒在口服给药系统中的应用 被引量:2

Application of Lipid Nanoparticles as Oral Drug Delivery System
下载PDF
导出
摘要 脂质纳米粒是由固体脂肪酸或其酯类制成的一类纳米制剂,其生物相容性好、安全性好,所以在药物递送领域受到广泛关注.难溶性药物、多肽及蛋白质药物由于溶解度、跨膜能力以及稳定性等问题,导致口服生物利用度低,而利用脂质纳米粒作为其载体,口服给药后能显著改善药物的生物利用度,这使得脂质纳米粒在口服给药系统中得到了广泛的应用与研究.本文从口服脂质纳米粒的处方、制备工艺、吸收机制以及应用四个方面对其进行了详细的综述. Lipid nanoparticles are prepared with solid fatty acids or esters, which is widely concerned in drug delivery due to their good biocompatiblity and safety. The oral bioavailability of poor-soluble drugs, peptides and proteins are very low because of their poor solubility, permeability or stability. However, lipid nanoparticles as their carrier can improve the oral bioavailability significantly, which enhance the application or investigation of lipid nanoparticles as oral drug delivery systems. This paper reviews the four aspects of lipid nanoparticles, including formualtion, preparation, absorption mechanism and application in oral delivery.
机构地区 复旦大学药学院
出处 《生物化学与生物物理进展》 SCIE CAS CSCD 北大核心 2013年第10期1008-1013,共6页 Progress In Biochemistry and Biophysics
基金 国家自然科学青年基金(81001405) 上海市教委曙光计划(10SG05) 教育部新世纪优秀人才支持计划(NCET-11-0114)资助项目~~
关键词 脂质纳米粒 口服 吸收机制 处方 应用 lipid nanparticles, oral, absorption mechanism, formulation, application
  • 相关文献

参考文献67

  • 1Gursoy R N, Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilie drugs. Biomed Pharmacother, 2004, 58(3): 173-182.
  • 2Amidon G L, Lcnnemas H, Shah V P, eta/. A theoretical basis for a hiopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailahility. Pharm Res, 1995, 12(3): 413-420.
  • 3Hauss D J. Oral lipid-based formulations. Adv Drug Deliv Rev, 2007, 59(7): 667-676.
  • 4Bysell H, Mansson R, Hansson P, et ol. Microgels and microcapsules in peptide and protein drug delivery. Adv Drug Deliv Rev, 2011, 63(13): 1172-1185.
  • 5Torchilin V P, Lukyanov A N. Peptide and protein drug delivery to and into tumors: challenges and solutions. Drug Discov Today, 2003, 8(6): 259-266.
  • 6Morishita M, Peppas N A. Is the oral route possible for peptide and protein drug delivery?. Drug Discov Today, 2006, 11(19 20): 905- 910.
  • 7Sahana D K, Mittal G, Bhardwaj V, et al. PLGA nanoparticles for oral delivery of hydrophobic drugs: influence of organic solvent on nanoparticle formation and release behavior in vitro and in vivo using estradiol as a model drug. J Pharm Sci, 2008, 97(4): 1530- 1542.
  • 8Xu Y, Liu X, Lian R, et ol bioavailability of aripiprazole Int J Pharm, 2012, 438(1-2): 287 Enhanced dissolution and oral nanosuspensions prepared by based on acid-base neutralization. -295.
  • 9Zhang K, Yu H, Luo Q, et ol. Increased dissolution and oral absorption of itraconazole/Soluplus extrudate compared with itraconazole nanosuspension. Eur J Pharm Biopharm, 2013, doi: 10.1016/j.ejpb.2013.1003.1002.
  • 10Niu M, Lu Y, Hovgaard L, et ol. Liposomes containing glycocholate as potential oral insulin delivery systems: preparation, in vitro characterization, and improved protection against enzymaticdegradation, hat J Nanomedicine, 2011, 6:1155-1166.

同被引文献54

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部